Serotonin 1(D) (5-HT(1D)) agonists and other agents in acute migraine

Neurologic Clinics

Volumn 15, Issue 1, 1997, Pages 61-83

  Mathew, N T ^a  

^a Houston Headache Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTIMIGRAINE AGENT; BUTORPHANOL; CAFERGOT; CHLORPROMAZINE; DIHYDROERGOTAMINE; ERGOMETRINE; ERGOTAMINE; ERGOTAMINE DERIVATIVE; FROVATRIPTAN; ISOMETHEPTENE MUCATE; LIDOCAINE; METHYSERGIDE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; NARCOTIC AGENT; PETHIDINE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; RIZATRIPTAN; SEDATIVE AGENT; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WIGRAINE; ZOLMITRIPTAN; ANALGESIC AGENT; VASOCONSTRICTOR AGENT;

BRONCHOSPASM; CLINICAL TRIAL; CORONARY ARTERY SPASM; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; FATIGUE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALAISE; MIGRAINE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE; TRIGEMINAL NERVE; VASOCONSTRICTION; ACUTE DISEASE; CLUSTER HEADACHE; DRUG INTERACTION; RECURRENT DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; CLUSTER HEADACHE; DIHYDROERGOTAMINE; DRUG INTERACTIONS; HUMANS; MIGRAINE DISORDERS; RECURRENCE; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0030614987     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70295-4     Document Type: Article

References (127)

1. B.E. Akpunonu A.B. Mutgi Sumatriptan and migraine [Letter] Ann Emerg Med 27 1996 387 388
2. B.E. Akpunonu A.B. Mutgi D.J. Federman Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: A multicenter study Ann Emerg Med 25 1995 464 469
3. Anonymous Sumatriptan: Rebound headache and migraine exacerbation Can Med Assoc J 152 1995 66
4. M. Banerjee L.J. Findley Sumatriptan in the treatment of acute migraine with aura Cephalalgia 12 1992 39 44
5. A.L. Basbaum H.L. Fields Endogenous pain central mechanisms: Review and hypothesis Ann Neurol 4 1978 451 462
6. D.N. Bateman Sumatriptan Lancet 341 1993 221 224
7. D. Bates E. Ashford R. Dawson Subcutaneous sumatriptan during the migraine aura Neurology 44 1994 1587 1592
8. M.J. Belgrade L.J. Ling M.B. Schleevogt Comparison of single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache Neurology 39 1989 590 592
9. P. Blier R. Bergeron The safety of concomitant use of sumatriptan and antidepressant treatments J Clin Psychopharmacol 15 1995 106 109
10. M.G. Bousser H. d'Allens A. Richard the Early Morning Migraine Sumatriptan Study Group Efficacy of subcutaneous sumatriptan in the acute treatment of early morning migraine: A placebo-controlled trial J Int Med 234 1993 211 216
11. I.W. Boyd A.P. Rohan Sumatriptan-induced chest pain [Letter] Lancet 344 1994 1704 1705
12. E.G. Brown C.A. Endersby R.N. Smith The safety and tolerability of sumatriptan: An overview Eur Neurol 31 1991 339 344
13. M.G. Buzzi W.B. Carter A. Shimizu Dihydroergotamine and sumatriptan alternate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion Neuropharmacology 30 1991 1193 2000
14. M.G. Buzzi V. Dimitriadou T.C. Theoharides 5-hydroxytryptamine receptor agonists for abortive treatment of vascular headaches block mass cell endothelial and platelet activation within the rat duramatter after trigeminal stimulation Brain Res 583 1992 137 149
15. R.K. Cady J. Dexter J.D. Sargent Efficacy of subcutaneous sumatriptan in repeated episodes of migraine Neurology 43 1993 1363 1366
16. R.K. Cady J. Rubino D. Crummett Oral sumatriptan in the treatment of recurrent headache Arch Fam Med 3 1994 766 772
17. R.K. Cady J.K. Wendt J.R. Kirchner Treatment of acute migraine with subcutaneous sumatriptan JAMA 265 1991 2831 2835
18. M. Callaham N. Raskin A controlled study of dihydroergotamine in the treatment of acute migraine headache Headache 26 1986 168 171
19. W.M. Castle V.E. Simmons Coronary vasospasm and sumatriptan [Letter] Br Med J 305 1992 117 118
20. T. Catarci F. Fiacco C. Argentino Ergotamine-induced headache can be sustained by sumatriptan daily intake Cephalalgia 14 1994 374 375
21. J.E. Cavazos J.B. Caress V.R. Chilukuri Sumatriptan-induced stroke in sagittal sinus thrombosis [Letter] Lancet 343 1994 1105 1106
22. Cerenex Pharmaceuticals, Division of Glaxo 1995 Research Triangle Park NC personal communication
23. A.H. Chester G.S. O'Neil M.H. Yacoub Sumatriptan and ischaemic heart disease [letter] Lancet 341 1993 1419 1420
24. 1 receptor Br J Pharmacol 108 1993 112 118
25. T. Curtin A.P. Brooks J.A. Roberts Cardiorespiratory distress after sumatriptan given by injection [Letter] Br Med J 305 1992 713 714
26. N. Cutler G.R. Mushet R. Davis Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths Neurology 45 suppl 7 1995 5 9
27. P. Czapinski A. Terezynski The use of sumatriptan in patients with concomitant migraine and epilepsy Cephalalgia 16 1996 385
28. C. Dahlof K. Ekbom L. Persson Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache Arch Neurol 51 1994 1256 1261
29. C.M. Dixon D.A. Saynor P.D. Andrew Disposition of sumatriptan in laboratory animals and humans Drug Metabol Disp 21 1993 761 769
30. J. Edmeads Emergency management of headache Headache 28 1988 675 679
31. K. Ekbom A. Krabbe G. Micelli for the Sumatriptan Cluster Headache Longterm Study Group Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg) Cephalalgia 15 1995 230 236
32. K. Ekbom I. Monstad A. Prusinski Subcutaneous sumatriptan in the acute treatment of cluster headache: A dose comparison study Acta Neurol Scand 88 1993 63 69
33. K. Ekbom E. Waldenlind J. Cole Sumatriptan in chronic cluster headache: Results of continuous treatment for eleven months Cephalalgia 12 1992 254 256
34. F.B.M. Ensink the Sumatriptan International Study Group Subcutaneous sumatriptan in the acute treatment of migraine J Neurol 238 suppl 1 1991 66 69
35. F. Facchinett G. Bonellie P. Kangasneimi for the Sumatriptan Menstrual Migraine Study Group The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine Obstet Gynecol 86 1995 911 916
36. 1-like agonists in the treatment of migraine J Neurol 238 suppl 1 1991 57 61
37. M.D. Ferrari M.H. James D. Bates Oral sumatriptan: Effect of a second dose, and incidence and treatment of headache recurrences Cephalalgia 14 1994 330 338
38. M.D. Ferrari P.R. Saxena Clinical and experimental effects of sumatriptan in humans Trends Pharmacol Sci 14 1993 129 133
39. M.D. Ferrari P.R.S. Saxena Clinical effects and mechanism of action of sumatriptan in migraine Clin Neurol Neurosurg 94 suppl 1992 73 77
40. M.D. Ferrari the Subcutaneous Sumatriptan International Study Group Treatment of migraine attacks with sumatriptan N Engl J Med 325 1991 316 321
41. P.A. Fowler L.F. Lacey M. Thomas The clinical pharmacology, pharmacokinetics, and metabolism of sumatriptan Eur Neurol 31 1991 291 294
42. D. Gaist S. Sindrup J. Hallas Misuse of sumatriptan [letter] Lancet 344 1994 1090
43. R.R. Ghose SUNCT syndrome [letter] Med J Aust 162 1995 667 668
44. Glaxo Wellcome: Imitrex (sumatriptan succinate) injection prescribing information. Research Triangle Park, NC, May 1996
45. Glaxo Welcome: Imitrex (sumatriptan succinate) tablets prescribing information. Research Triangle Park, NC, June 1995
46. 3H-dihydroergotamine-binding sites in the cat central nervous system: Relevance to migraine Ann Neurol 29 1991 91 94
47. P.J. Goadsby A.S. Zagami G.A. Donnan Oral sumatriptan in acute migraine Lancet 338 1991 782 783
48. P.J. Goadsby L. Edvinson Human in vivo evidence for trigeminal vascular activation in cluster headache: Neuropeptide changes and effects of acute attack therapies Brain 117 1994 427 434
49. 1D) receptor agonist 311C90 Headache 34 1994 394 399
50. P.J. Goadsby K.L. Hosken Trigeminal neuronal activity is inhibited by intravenous administration of 311C90 in the cat Cephalalgia 15 Suppl 14 1995 116
51. M.L.P. Gross J. Kay A.M. Turnere Sumatriptan in acute migraine using a novel cartridge system self-injector Headache 34 1994 559 563
52. J.E. Hardebo Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms Headache 33 1993 18 21
53. P. Henry H. d'Allens French Migraine Network Bordeaux-Lyon-Grenoble Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis Headache 33 1993 432 435
54. W.S. Hillis P.D. MacIntyre Sumatriptan and chest pain [letter] Lancet 342 1993 683
55. W.S. Hillis P.D. MacIntyre Sumatriptan and chest pain [letter] Lancet 341 1993 1564 1565
56. W. Inman K. Kubota Cardiorespiratory distress after sumatriptan given by injection [Letter] Br Med J 305 1992 714
57. K.V. Iserson Parenteral chlorpromazine treatment of migraine Ann Emerg Med 12 1983 756 758
58. J. Jacob P.J. Goadsby J.S. Duncan Use of sumatriptan in post-ictal migraine Headache 47 1996 1104
59. N.C. Jackson A comparison of oral eletriptan (UK 116,044) (20-80 mg) and oral sumatriptan (100mg) in the acute treatment of migraine Cephalalgia 16 1996 368
60. J.E.L. Jayamaha M.K. Street Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan Intensive Care Med 21 1995 82 83
61. I. Jones D. Sklar J. Dougherty Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache JAMA 261 1989 1734 1736
62. S. Jones D. Sklar J. Dougherty Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache JAMA 261 1989 1174 1176
63. H. Kaube A. May H.C. Diener Sumatriptan Br Med J 308 1994 1573 1574
64. K.M. Kelly Cardiac arrest following use of sumatriptan Neurology 45 1995 1211 1213
65. R.B. Klein A review of the efficacy of zolmitriptan (311C90) a new acute treatment of migraine Cephalalgia 15 suppl 14 1995 159
66. L. Kudrow D.B. Kudrow J.H. Sandweiss Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings Headache 35 1995 79 82
67. L.F. Lacey P.A. Fowler The clinical pharmacology of sumatriptan [abstract] Cephalalgia 13 suppl 13 1993 156
68. M. Lai V. Loi A. Cherchi Can sumatriptan be anxiogenic in migraineurs? Cephalalgia 16 1996 384 385
69. P.L. Lane R. Ross Intravenous chlorpromazine: Preliminary results in acute migraine Headache 25 1985 302 304
70. S.L. Linder Subcutaneous sumatriptan in the clinical setting: The first 50 consecutive patients with acute migraine in pediatric neurology office practice Headache 36 1996 419 422
71. D.K. Lloyd W.S.G. Arnold Long-term use of sumatriptan [letter] Br Med J 308 1994 533
72. D.K. Lloyd A.J. Pilgrim The safety of sumatriptan in asthmatic migraineurs Cephalalgia 13 1993 201 204
73. W. Luman R.S. Gray Adverse reactions associated with sumatriptan [letter] Lancet 341 1993 1091 1092
74. M. Maizels B. Scott W. Cohen Intranasal lidocaine for treatment of migraine JAMA 276 1996 319 321
75. D.A. Marks B.L. Ehrenberg Migraine-related seizures in adults with epilepsy, with EEG correlation Neurology 43 1993 2476 2483
76. N.T. Mathew J. Dexter J. Couch Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine Arch Neurol 49 1992 1271 1276
77. N.T. Mathew R. Kurman F. Perez Drug-induced refractory headache-clinical features and management Headache 30 1990 634 638
78. N.T. Mathew Long-term subcutaneous sumatriptan in cluster headache [editorial] Cephalalgia 15 1995 164
79. N.T. Mathew G. Tietjen C. Lucker Serotonin syndrome complicating migraine pharmacotherapy Cephalalgia 16 1996 323 327
80. K.C. Mills Serotonin syndrome Am Fam Physician 52 1995 1474 1482
81. I. Monstad A. Krabbe G. Micieli Preemptive oral treatment with sumatriptan during a cluster period Headache 35 1995 607 613
82. M.A. Moskowitz Neurogenic inflammation in the pathophysiology and treatment of migraine Neurology 43 suppl 3 1993 16 20
83. M.A. Moskowitz R. MacFarlane Neurovascular and molecular mechanism in migraine headache Cerebrovascular Brain Metab Rev 5 1993 150 177
84. L. Mueller R.M. Gallagher C.A. Ciervo Vasospasm-induced myocardial infarction with sumatriptan Headache 36 1996 329 331
85. R.J. Myerburg K.M. Kessler S.M. Mallon Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm N Engl J Med 326 1992 1451 1455
86. G. Nappi F. Sicuteri M. Byrne Oral sumatriptan compared with placebo in the acute treatment of migraine J Neurol 241 1994 138 144
87. M.J. Osborne R.C.T. Austin K.J. Dawson Is there a problem with long term use of sumatriptan in acute migraine? Br Med J 308 1994 113
88. R. Ottman R.B. Lipton Comorbidity of migraine and epilepsy Neurology 44 1994 2105 2110
89. J.P. Ottervanger H.J.A. Paalman G.L. Boxma Transmural myocardial infarction with sumatriptan Lancet 341 1993 861 862
90. L.A. Pini T. Trenti Does chronic use of sumatriptan induce independence? Headache 34 1994 600
91. G.L. Plosker D. McTavish Sumatriptan: A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache Drugs 47 1994 622 651
92. A.M. Rapoport W.H. Visser N.R. Cutler Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan Neurology 45 1995 1505 1509
93. N.H. Raskin Repetitive intravenous dihydroergotamine as therapy for intractable migraine Neurology 36 1986 995 997
94. G. Rederich A. Rapoport N. Cutler Oral sumatriptan for the long-term treatment of migraine: Clinical findings Neurology 45 suppl 7 1995 15 20
95. M.B. Russell O.E. Holm-Thomsen M.R. Nielsen A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice Cephalalgia 14 1994 291 296
96. H.A. Saadah Abortive headache therapy in the office with intravenous dihydroergotamine in the treatment of acute migraine headache Headache 32 1992 143 146
97. J. Schoenen J. Bulcke J. Caekebeke Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: Comparison with customary treatment in an open, longitudinal study Cephalalgia 14 1994 55 63
98. J. Schoenen K.B. Klein 311C90 and sumatriptan produce indistinguishable CNS adverse event profiles Cephalalgia 16 1996 389 390
99. A.K. Scott T. Walley A.M. Breckenridge Lack of an interaction between propranolol and sumatriptan Br J Clin Pharmacol 32 1991 581 584
100. F.D. Sheftell Subcutaneous sumatriptan in a clinical setting: The first 100 consecutive patients with acute migraine in a tritiary care center Headache 34 1994 67 72
101. S.D. Silberstein E.A. Schulman M.M. Hopkins Repetitive intravenous DHE in the treatment of refractory headache Headache 30 1990 334 339
102. M.P. Solbach R.S. Waymer Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan Obstet Gynecol 82 1993 769 772
103. S.J. Stratton Sumatriptan and migraine [letter] Ann Emerg Med 27 1996 388
104. S.J. Stratton Sumatriptan: A clinical standard? Ann Emerg Med 25 1995 538 539
105. B.H.C. Stricker Coronary vasospasm and sumatriptan [letter] Br Med J 305 1992 118
106. O. Suchowersky Rebound headaches due to sumatriptan [Abstract 658P] Neurology 43 Suppl 2 1993 326
107. R.S. Sykes W. Castle J. Palmer Sumatriptan-induced stroke in sagittal sinus thrombosis [Letter] Lancet 343 1994 1299 1300
108. C.P. Szabo Fluoxetine and sumatriptan: Possibly a counterproductive sufferer whilst receiving sumatriptan [letter] J Clin Psychiatry 56 1995 37 38
109. M.J.B. Tansey A.J. Pilgrim K. Lloyd Sumatriptan in the acute treatment of migraine J Neurol Sci 114 1993 109 116
110. M.J.B. Tansey A.J. Pilgrim P.M. Martin Long-term experience with sumatriptan in the treatment of migraine Eur Neurol 33 1993 310 315
111. P. Tfelt-Hansen B. Sperling P.D. Winter Transient additional effect of sumatriptan on ergotamine-induced constriction of peripheral arteries in man [abstract] Clin Pharmacol Ther 51 1992 149
112. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine Eur Neurol 31 1991 332 338
113. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group A randomized double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine Eur Neurol 31 1991 314 322
114. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine Eur Neurol 32 1992 177 184
115. The Oral Sumatriptan Dose-Defining Study Group Sumatriptan: An oral dose-defining study Eur Neurol 31 1991 300 305
116. The Oral Sumatriptan International Multiple-Dose Study Group Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine Eur Neurol 31 1991 306 313
117. The Sumatriptan Auto-Injector Study Group Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device Eur Neurol 31 1991 323 331
118. The Sumatriptan Cluster Headache Study Group Treatment of acute cluster headache with sumatriptan N Engl J Med 325 1991 322 326
119. W.H. Visser C.R. Lines S.A. Reins Dose finding studies of rizatriptan (MK-462) in the acute treatment of migraine Cephalalgia 16 1996 359
120. W.H. Visser R.H.M. DeVriend N.H.W.M. Jaspers Sumatriptan-nonresponders: A survey of 366 patients Headache 36 1996 471 475
121. W.H. Visser R.H.M. DeVriend N.M.W.H. Jaspers Sumatriptan in clinical practice a two-year review of 453 migraine patients Neurology 47 1996 46 51
122. W.H. Visser N.M.W.H. Jaspers R.H.M. DeVriend Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients Cephalalgia 16 1996 264 269
123. M. Wilkinson V. Pffafenrath J. Schoenen Migraine and cluster headache: Their management with sumatriptan: A critical review of the current clinical experience Cephalalgia 15 1995 337 357
124. F. Willett N. Curzen J. Adams Coronary vasospasm induced by subcutaneous sumatriptan [letter] Br Med J 304 1992 1415
125. Y.K. Wing E.M. Clifford B.D. Sheehan Paroxetine treatment and the prolactin response to sumatriptan Psychopharmacology 124 1996 377 379
126. P. Winner D. Dalessio N. Mathew Office based treatment of acute migraine with dihydroergotamine mesylate Headache 33 1993 471 475
127. P. Winner O. Ricalde B. Le Force A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine Arch Neurol 53 1996 180 184